Sriram G - Search Results

1

Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.

Saleh T, Jankowski W, Sriram G, Rossi P, Shah S, Lee KB, Cruz LA, Rodriguez AJ, Birge RB, Kalodimos CG. Saleh T, et al. Among authors: sriram g. Nat Chem Biol. 2016 Feb;12(2):117-23. doi: 10.1038/nchembio.1981. Epub 2015 Dec 14. Nat Chem Biol. 2016. PMID: 26656091 Free PMC article.

2

Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.

Jankowski W, Saleh T, Pai MT, Sriram G, Birge RB, Kalodimos CG. Jankowski W, et al. Among authors: sriram g. Nat Chem Biol. 2012 May 13;8(6):590-6. doi: 10.1038/nchembio.954. Nat Chem Biol. 2012. PMID: 22581121 Free PMC article.

3

Commentary: The carboxyl-terminal Crk SH3 domain: Regulatory strategies and new perspectives.

Sriram G, Birge RB. Sriram G, et al. FEBS Lett. 2012 Aug 14;586(17):2615-8. doi: 10.1016/j.febslet.2012.04.040. Epub 2012 May 2. FEBS Lett. 2012. PMID: 22710158 Free article. Review.

4

Crk at the quarter century mark: perspectives in signaling and cancer.

Kumar S, Fajardo JE, Birge RB, Sriram G. Kumar S, et al. Among authors: sriram g. J Cell Biochem. 2014 May;115(5):819-25. doi: 10.1002/jcb.24749. J Cell Biochem. 2014. PMID: 24356912

5

Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.

Sriram G, Reichman C, Tunceroglu A, Kaushal N, Saleh T, Machida K, Mayer B, Ge Q, Li J, Hornbeck P, Kalodimos CG, Birge RB. Sriram G, et al. Oncogene. 2011 Nov 17;30(46):4645-55. doi: 10.1038/onc.2011.170. Epub 2011 May 23. Oncogene. 2011. PMID: 21602891 Free PMC article.

6

Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.

Sriram G, Jankowski W, Kasikara C, Reichman C, Saleh T, Nguyen KQ, Li J, Hornbeck P, Machida K, Liu T, Li H, Kalodimos CG, Birge RB. Sriram G, et al. Oncogene. 2015 Aug 6;34(32):4260-9. doi: 10.1038/onc.2014.361. Epub 2014 Nov 10. Oncogene. 2015. PMID: 25381819 Free PMC article.

7

Emerging roles for crk in human cancer.

Sriram G, Birge RB. Sriram G, et al. Genes Cancer. 2010 Nov;1(11):1132-9. doi: 10.1177/1947601910397188. Genes Cancer. 2010. PMID: 21779437 Free PMC article.

8

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.

Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, Sriram G, Devoe C, Nguyen KN, Antes A, Krantz A, Rymarczyk G, Wilczynski A, Empig C, Freimark B, Gray M, Schlunegger K, Hutchins J, Kotenko SV, Birge RB. Kasikara C, et al. Among authors: sriram g. Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9. Mol Cancer Res. 2017. PMID: 28184013 Free PMC article.

9

Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity.

Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y, Birge RB. Kimani SG, et al. Among authors: sriram g. Front Immunol. 2014 Nov 10;5:566. doi: 10.3389/fimmu.2014.00566. eCollection 2014. Front Immunol. 2014. PMID: 25426118 Free PMC article. Review.

10

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.

Kasikara C, Davra V, Calianese D, Geng K, Spires TE, Quigley M, Wichroski M, Sriram G, Suarez-Lopez L, Yaffe MB, Kotenko SV, De Lorenzo MS, Birge RB. Kasikara C, et al. Among authors: sriram g. Cancer Res. 2019 May 15;79(10):2669-2683. doi: 10.1158/0008-5472.CAN-18-2614. Epub 2019 Mar 15. Cancer Res. 2019. PMID: 30877108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page